Intermountain Health logo

Please enter the city or town where you'd like to find care.

Get care nowSign in

Health news and blog

    Precision Medicine is Lengthening Survival Without Increasing Cost

    Precision Medicine is Lengthening Survival Without Increasing Cost

    nadauld

    Results of the study, which were released in the Journal of Oncology Practice, found that:

    • Patients who received precision cancer medicine experienced an improved progression-free survival of 22.9 weeks, compared with 12 weeks for patients receiving standard treatments.
    • Survival rates were not associated with increased medical costs:  In an analysis of patients who received all care within the Intermountain Healthcare system, patient charges were actually less in the precision treatment group than the control group. 

    Seventy-two patients with metastatic cancer of diverse subtypes were treated in the setting of a large, integrated healthcare delivery system between July 1, 2013 and January 31, 2015. 

    Find the full study, A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Costs.